目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global red biotechnology market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global red biotechnology market 2018 - 2022 ($ billion)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Monoclonal antibodies - Market size and forecast 2023-2028
Exhibit 34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
6.4 Gene therapy - Market size and forecast 2023-2028
Exhibit 38: Chart on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
6.5 Polyclonal antibodies - Market size and forecast 2023-2028
Exhibit 42: Chart on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
6.6 Cell-based immunotherapy products - Market size and forecast 2023-2028
Exhibit 46: Chart on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ billion)
Exhibit 55: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by End-user
7.1 Market segments
Exhibit 56: Chart on End-user - Market share 2023-2028 (%)
Exhibit 57: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 58: Chart on Comparison by End-user
Exhibit 59: Data Table on Comparison by End-user
7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
Exhibit 60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
7.4 CMOs and CROs - Market size and forecast 2023-2028
Exhibit 64: Chart on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on CMOs and CROs - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on CMOs and CROs - Year-over-year growth 2023-2028 (%)
7.5 Academic research institutes - Market size and forecast 2023-2028
Exhibit 68: Chart on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Data Table on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 70: Chart on Academic research institutes - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Academic research institutes - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 72: Market opportunity by End-user ($ billion)
Exhibit 73: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 Germany - Market size and forecast 2023-2028
Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Amgen Inc.
Exhibit 123: Amgen Inc. - Overview
Exhibit 124: Amgen Inc. - Product / Service
Exhibit 125: Amgen Inc. - Key offerings
12.4 Astellas Pharma Inc.
Exhibit 126: Astellas Pharma Inc. - Overview
Exhibit 127: Astellas Pharma Inc. - Product / Service
Exhibit 128: Astellas Pharma Inc. - Key news
Exhibit 129: Astellas Pharma Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 130: AstraZeneca Plc - Overview
Exhibit 131: AstraZeneca Plc - Product / Service
Exhibit 132: AstraZeneca Plc - Key news
Exhibit 133: AstraZeneca Plc - Key offerings
12.6 Bayer AG
Exhibit 134: Bayer AG - Overview
Exhibit 135: Bayer AG - Business segments
Exhibit 136: Bayer AG - Key news
Exhibit 137: Bayer AG - Key offerings
Exhibit 138: Bayer AG - Segment focus
12.7 Biogen Inc.
Exhibit 139: Biogen Inc. - Overview
Exhibit 140: Biogen Inc. - Product / Service
Exhibit 141: Biogen Inc. - Key offerings
12.8 Boehringer Ingelheim International GmbH
Exhibit 142: Boehringer Ingelheim International GmbH - Overview
Exhibit 143: Boehringer Ingelheim International GmbH - Business segments
Exhibit 144: Boehringer Ingelheim International GmbH - Key news
Exhibit 145: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 146: Boehringer Ingelheim International GmbH - Segment focus
12.9 Bristol Myers Squibb Co.
Exhibit 147: Bristol Myers Squibb Co. - Overview
Exhibit 148: Bristol Myers Squibb Co. - Product / Service
Exhibit 149: Bristol Myers Squibb Co. - Key news
Exhibit 150: Bristol Myers Squibb Co. - Key offerings
12.10 Bruker Corp.
Exhibit 151: Bruker Corp. - Overview
Exhibit 152: Bruker Corp. - Business segments
Exhibit 153: Bruker Corp. - Key news
Exhibit 154: Bruker Corp. - Key offerings
Exhibit 155: Bruker Corp. - Segment focus
12.11 F. Hoffmann La Roche Ltd.
Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Gilead Sciences Inc.
Exhibit 161: Gilead Sciences Inc. - Overview
Exhibit 162: Gilead Sciences Inc. - Product / Service
Exhibit 163: Gilead Sciences Inc. - Key news
Exhibit 164: Gilead Sciences Inc. - Key offerings
12.13 Merck KGaA
Exhibit 165: Merck KGaA - Overview
Exhibit 166: Merck KGaA - Business segments
Exhibit 167: Merck KGaA - Key news
Exhibit 168: Merck KGaA - Key offerings
Exhibit 169: Merck KGaA - Segment focus
12.14 Pfizer Inc.
Exhibit 170: Pfizer Inc. - Overview
Exhibit 171: Pfizer Inc. - Product / Service
Exhibit 172: Pfizer Inc. - Key news
Exhibit 173: Pfizer Inc. - Key offerings
12.15 Regeneron Pharmaceuticals Inc.
Exhibit 174: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 175: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 176: Regeneron Pharmaceuticals Inc. - Key offerings
12.16 STEMCELL Technologies Inc.
Exhibit 177: STEMCELL Technologies Inc. - Overview
Exhibit 178: STEMCELL Technologies Inc. - Product / Service
Exhibit 179: STEMCELL Technologies Inc. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 180: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 181: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 182: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 183: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 184: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 185: Inclusions checklist
Exhibit 186: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 187: Currency conversion rates for US$
13.4 Research methodology
Exhibit 188: Research methodology
Exhibit 189: Validation techniques employed for market sizing
Exhibit 190: Information sources
13.5 List of abbreviations
Exhibit 191: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global red biotechnology market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
Exhibits47: Data Table on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
Exhibits48: Chart on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits54: Market opportunity by Product ($ billion)
Exhibits55: Data Table on Market opportunity by Product ($ billion)
Exhibits56: Chart on End-user - Market share 2023-2028 (%)
Exhibits57: Data Table on End-user - Market share 2023-2028 (%)
Exhibits58: Chart on Comparison by End-user
Exhibits59: Data Table on Comparison by End-user
Exhibits60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on CMOs and CROs - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on CMOs and CROs - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Data Table on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Chart on Academic research institutes - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Academic research institutes - Year-over-year growth 2023-2028 (%)
Exhibits72: Market opportunity by End-user ($ billion)
Exhibits73: Data Table on Market opportunity by End-user ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits113: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ billion)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits117: Impact of drivers and challenges in 2023 and 2028
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Amgen Inc. - Overview
Exhibits124: Amgen Inc. - Product / Service
Exhibits125: Amgen Inc. - Key offerings
Exhibits126: Astellas Pharma Inc. - Overview
Exhibits127: Astellas Pharma Inc. - Product / Service
Exhibits128: Astellas Pharma Inc. - Key news
Exhibits129: Astellas Pharma Inc. - Key offerings
Exhibits130: AstraZeneca Plc - Overview
Exhibits131: AstraZeneca Plc - Product / Service
Exhibits132: AstraZeneca Plc - Key news
Exhibits133: AstraZeneca Plc - Key offerings
Exhibits134: Bayer AG - Overview
Exhibits135: Bayer AG - Business segments
Exhibits136: Bayer AG - Key news
Exhibits137: Bayer AG - Key offerings
Exhibits138: Bayer AG - Segment focus
Exhibits139: Biogen Inc. - Overview
Exhibits140: Biogen Inc. - Product / Service
Exhibits141: Biogen Inc. - Key offerings
Exhibits142: Boehringer Ingelheim International GmbH - Overview
Exhibits143: Boehringer Ingelheim International GmbH - Business segments
Exhibits144: Boehringer Ingelheim International GmbH - Key news
Exhibits145: Boehringer Ingelheim International GmbH - Key offerings
Exhibits146: Boehringer Ingelheim International GmbH - Segment focus
Exhibits147: Bristol Myers Squibb Co. - Overview
Exhibits148: Bristol Myers Squibb Co. - Product / Service
Exhibits149: Bristol Myers Squibb Co. - Key news
Exhibits150: Bristol Myers Squibb Co. - Key offerings
Exhibits151: Bruker Corp. - Overview
Exhibits152: Bruker Corp. - Business segments
Exhibits153: Bruker Corp. - Key news
Exhibits154: Bruker Corp. - Key offerings
Exhibits155: Bruker Corp. - Segment focus
Exhibits156: F. Hoffmann La Roche Ltd. - Overview
Exhibits157: F. Hoffmann La Roche Ltd. - Business segments
Exhibits158: F. Hoffmann La Roche Ltd. - Key news
Exhibits159: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits160: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits161: Gilead Sciences Inc. - Overview
Exhibits162: Gilead Sciences Inc. - Product / Service
Exhibits163: Gilead Sciences Inc. - Key news
Exhibits164: Gilead Sciences Inc. - Key offerings
Exhibits165: Merck KGaA - Overview
Exhibits166: Merck KGaA - Business segments
Exhibits167: Merck KGaA - Key news
Exhibits168: Merck KGaA - Key offerings
Exhibits169: Merck KGaA - Segment focus
Exhibits170: Pfizer Inc. - Overview
Exhibits171: Pfizer Inc. - Product / Service
Exhibits172: Pfizer Inc. - Key news
Exhibits173: Pfizer Inc. - Key offerings
Exhibits174: Regeneron Pharmaceuticals Inc. - Overview
Exhibits175: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits176: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits177: STEMCELL Technologies Inc. - Overview
Exhibits178: STEMCELL Technologies Inc. - Product / Service
Exhibits179: STEMCELL Technologies Inc. - Key offerings
Exhibits180: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits181: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits182: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits183: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits184: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits185: Inclusions checklist
Exhibits186: Exclusions checklist
Exhibits187: Currency conversion rates for US$
Exhibits188: Research methodology
Exhibits189: Validation techniques employed for market sizing
Exhibits190: Information sources
Exhibits191: List of abbreviations